HOPCo acquires the digital health platform, MyACTome

This partnership will dramatically streamline the rollout of evidence-based protocols, automated clinical decision support, remote care management, and value-based care programs. HOPCo Partners with Future Health Works to Acquire Musculoskeletal Patient Engagement and Outcomes Tracking Platform (press release)

HOPCo (Healthcare Outcomes Performance Company), the leader in musculoskeletal (MSK) clinical outcomes management solutions and the country’s largest orthopedic value-based care organization, continues its digital health platform expansion with its acquisition of MyACTome. As the only validated smartphone-based fall risk and frailty assessment platform, MyACTome leverages the existing motion sensors within a smartphone to assess patient balance, walking dynamics, and dynamic stability patterns to quantify patient biomechanical performance, frailty score, and fall risk – allowing risk stratification of patients.  Given that each year in the U.S. alone, more than $50 billion is spent on medical costs related to older adult falls, integrated technologies such as MyACTome represent a massive opportunity to improve patient safety while lowering avoidable injuries and musculo...


Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !
 

Scroll to Top